U.S. Regulation

Canary Capital Registers Staked Injective ETF in Delaware

The trust’s registration is just the beginning. To make the ETF officially recognized and listed, Canary Capital must file a Form S-1 registration statement with the U.S. Securities and Exchange Commission (SEC). This is a necessary procedure for obtaining approval from the SEC, which oversees securities offerings in the U.S. Once the Form S-1 is filed, the SEC will review the application before granting approval.

Additionally, Canary Capital will need to submit a Form 19b-4 filing. This filing will be made through the exchange where the ETF is intended to be listed. These filings are crucial steps toward bringing the ETF to market. As of now, the official filings are not yet available on the SEC website. Canary Capital has made prior filings with the SEC for other cryptocurrencies, including TRON (TRX), Sui (SUI), and PENGU.

These filings reflect the firm’s broader strategy of expanding its offerings in the crypto market by providing new investment opportunities tied to cryptocy assets. The Canary Staked Injective ETF aims to track the spot price of Injective (INJ), while also earning additional INJ tokens through staking. Staking is a process where holders of a cryptocy lock up their tokens to support network operations, such as transaction validation, in exchange for rewards.

In this case, investors in the ETF would gain exposure to both the market price of INJ and the staking rewards generated through the Injective blockchain just like the Solana ETF. This design offers convenience for investors since it allows investors to gain exposure to INJ without having to stake INJ directly. In doing this, this setup makes it easier for people who would like to participate through the staking rewards program but may not have the technical know how or interest in managing their own staking operations.

Canary Capital’s announcement comes amid other financial firms starting to offer similar crypto – backed investment products. In particular, 21Shares’s Injective Staking Exchange Traded Product (ETP), called AINJ, is a 100% physically backed product. While reinvesting staking rewards back into the ETP, AINJ tracks the performance of INJ.

This product is already on Euronext Amsterdam and Paris, enabling exposure to INJ and staking rewards for crypto investors. AINJ is asset backed by INJ tokens held in an institutionally grade custodian. Several prominent financial institutions including Interactive Brokers, Saxo Bank, Swissquote and eToro have supported this ETP.

Terron Gold

Recent Posts

Elon Musk’s xAI Sues Minnesota Over First U.S. AI Nudification Law

Elon Musk's artificial intelligence company xAI has filed a federal lawsuit challenging Minnesota's landmark law banning AI-powered "nudification" technology, arguing…

6 days ago

Bitcoin Nears $65,000 as Treasury Yields Outperform Carry Trade in Rare Market Signal

Bitcoin climbed toward $65,000 as an unusual shift in traditional financial markets created one of the rarest conditions…

7 days ago

Hyperscale Data Sells 100 Bitcoin to Fund Michigan AI Campus as GPUS Stock Surges

Hyperscale Data has sold 100 Bitcoin to accelerate development of its planned artificial intelligence campus in Michigan, sending shares…

7 days ago

PIPEDOG Explodes 140x on Robinhood Chain as Memecoin Frenzy Intensifies

A newly launched memecoin called PIPEDOG ($PIPEDOG) became the latest breakout token on Robinhood Chain, surging more than 140x within…

1 week ago

BNY Brings $8.6 Trillion Fund Business On-Chain in Major Wall Street Blockchain Expansion

BNY, the world's largest custodian bank, is bringing one of its core financial businesses onto…

1 week ago

Senators Strengthen Crypto Ethics Rules in CLARITY Act After Trump Negotiations

A bipartisan group of U.S. senators has reportedly reached a new compromise on the ethics provisions of…

1 week ago